Products
Latest News
FAQ
Log in
|
Search
Search
Filters
Clear All
Study Phase
Early Phase 1
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
Phase 4
Not Applicable
Recruitment Status
Recruiting
Not yet recruiting
Active, not recruiting
Completed
Suspended
Terminated
Withdrawn
Study Type
Interventional
Observational
Expanded Access
Others
Eligibility Sex
All
Female
Male
Healthy Volunteers
All
Include
Exclude
Found
1
clinical trials
|
View Analysis
Sort by:
Newest First
Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis
Phase 2
Conditions
Onchocerciasis
Tropical Disease
Onchocerciasis, Ocular
Onchocerca Infection
Onchocercal Subcutaneous Nodule
Interventions
Drug: Moxidectin + Albendazole
Drug: Ivermectin w/ Albendazole
Drug: Ivermectin + Diethylcarbamazine + Albendazole
Drug: Moxidectin + Diethylcarbamazine + Albendazole
Subscribe
First Posted Date
2023-10-06
Last Posted Date
2024-06-04
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
300
Registration Number
NCT06070116
Locations
🇱🇷
Bong County Hospital, Bong Town, Bong County, Liberia
Subscribe
Prev
1
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy